Which local anesthetic is associated with a higher risk of adverse cardiovascular events?

• A. Lidocaine
• B. Bupivacaine
• C. Mepivacaine
• D. Articaine

Answer: (B)

Bupivacaine is the local anesthetic associated with a higher risk of adverse cardiovascular events due to its unique pharmacological properties. It is a long-acting amide anesthetic that has a higher lipid solubility, leading to a greater potential for systemic toxicity, particularly in the cardiovascular system. When bupivacaine enters the bloodstream, it can bind to sodium channels in cardiac tissues, resulting in potential life-threatening arrhythmias, hypotension, and cardiovascular collapse.

This increased risk is particularly significant in scenarios where large doses are used or when the drug is inadvertently injected into a blood vessel. The effects of bupivacaine on the cardiovascular system are typically more pronounced and less reversible than those of other local anesthetics, such as lidocaine, mepivacaine, and articaine, which tend to have a lower toxicity profile in that aspect.

Lidocaine, mepivacaine, and articaine, while still capable of causing adverse effects, do not carry the same level of risk for severe cardiovascular events when used appropriately. Therefore, the careful consideration of bupivacaine's effects is essential when planning local anesthesia procedures.